Responsibilities of the Associate Director Market Access and Public Affairs DACH (m/f/d) include: Focuses on coordination and execution of Idorsia-s access strategy and its implementation (project management, oversees dossier writing, timelines, risks etc.) for defined therapeutic area. Ensures local fit of product value proposition (incl. evidence) to obtain ideal pricing and reimbursement scenarios and outcome. Represents Idorsia vis-à-vis local external agencies and other stakeholders, e.g. pharma association working groups and patient advocacy groups. Actively contributes to the internal Idorsia processes and contributes significantly to the conceptual development and implementation of country Market Access and Public Affairs strategies. Regularly exchanges information with the Senior Market Access and Public Affairs Director DACH and cross-functional project teams. Drives development and implementation of country strategies to support DACH Market Access and Public Affairs. Monitors the relevant regional policy environment and understands key healthcare trends and their impact. Builds and maintains long-term relationships throughout the Idorsia DACH organization and with external regional counterparts. Ensure adherence to all relevant legal, regulatory, and healthcare compliance requirements, corporate policies, and procedures, and drive this culture in the local organization.
The purpose of Idorsia is to discover, develop and bring more innovative medicines to patients. We have more ideas; we see more opportunities and we want to help more patients. In order to achieve this, we would like to develop Idorsia into one of Europe-s leading biopharmaceutical companies, with a strong scientific core. Idorsia is headquartered in Switzerland and has already established commercial operations in the US, Canada and major strategic locations in Europe. With the commercial operations for the DACH region based in Munich/ Germany and Allschwil/ Switzerland, we are helping to realize Idorsia-s ambition of bringing innovative medicines from bench to bedside.